Some issues on chemotherapy for advanced non-small cell lung cancer
HU Jie
BAI Chun-xue
Abstract:Lung cancer is the leading cause of morbidity and mortality of malignant tumor.Surgery,radiotherapy and chemotherapy remain the primary means of treatment for lung cancer,while the discoveries of molecular targets and targeted agents for lung cancer are making revolutionary changes and will almost certainly propel progress in this field into the foreseeable future.Biomarker-based individualized comprehensive treatment strategy is expected to benefit the lung cancer patients'survival.Meanwhile,chemotherapy remains the major treatment of advanced non-small cell lung cancer,which requires implementing the "three combinations" dialectical therapy principles,that is,systemic with local,conventional with personalized,eliminating with supporting.
Keywords:lung cancerchemotherapytarget therapy
Publication Date:2010-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:3( 298-300 )
CHINESE JOURNAL OF PRACTICAL INTERNAL MEDICINE

CHINESE JOURNAL OF PRACTICAL INTERNAL MEDICINE

PKUISTIC
ISSN:1005-2194
Year, Vol.(Issue):2010,30(4)